Nanosonics

Rising Global Aging And Regulatory Demands Will Accelerate Automated Disinfection

AnalystHighTarget

Not Invested

Consensus Narrative from 8 Analysts

Published

17 Jul 25

AnalystHighTarget's Fair Value

AU$6.18

32.7% undervalued

10 Sep

AU$4.16

15.6%

6.9%

15.6%

6.9%

You can edit this narrative until Jul 17 9:21 PM. Then, changes will post as Updates.

Author's Valuation

AU$6.2

32.7% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

AU$6.18

32.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

9.17%

Medical Equipment revenue growth rate

0.40%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.04%

Calculation

AU$57.36m

Earnings '28

39.26x

PE Ratio '28

AU$2.25b

Market Cap '28

AU$2.25b

Market Cap '28

297.23m

No. shares '28

AU$7.58

Share Price '28

AU$7.58 Share Price '28

Discounted to 2025 @ 7.05% p.a.

AU$6.18

Fair Value '25